- You are viewing a Navigating Care library resource.
- Go to Library
Treatment of Stages IVA, IVB, and IVC Salivary Gland Cancer
For information about the treatments listed below, see the Treatment Option Overview section.
Treatment of stage IVA, stage IVB, and stage IVC salivary gland cancer may include the following:
- Fast neutron or photon-beam radiation therapy.
- A clinical trial of chemotherapy with or without radiation therapy.
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
This information is not intended to replace the advice of a doctor.
Navigating Care disclaims any liability for the decisions you make based on this information.
This information was sourced and adapted from Adapted from the National Cancer Institute's
Physician Data Query (PDQ®) Cancer Information Summaries on
www.cancer.gov.
This information updated
November 1, 2024.
Learn more:
- General Information About Salivary Gland Cancer
- Stages of Salivary Gland Cancer
- Treatment Option Overview
- Treatment of Stage I Salivary Gland Cancer
- Treatment of Stage II Salivary Gland Cancer
- Treatment of Stage III Salivary Gland Cancer
- Treatment of Stages IVA, IVB, and IVC Salivary Gland Cancer
- Treatment of Recurrent Salivary Gland Cancer
- To Learn More About Salivary Gland Cancer
Related Articles
- General Information About Salivary Gland Cancer
- Stages of Salivary Gland Cancer
- Treatment Option Overview
- Treatment of Stage I Salivary Gland Cancer
- Treatment of Stage II Salivary Gland Cancer
- Treatment of Stage III Salivary Gland Cancer
- Treatment of Stages IVA, IVB, and IVC Salivary Gland Cancer
- Treatment of Recurrent Salivary Gland Cancer
- To Learn More About Salivary Gland Cancer
See Expert Resources
The Navigating Care Library includes articles about cancer, chemotherapy regimens and drugs from the
the National Cancer Institute and other experts.
